Generics

Filter

Current filters:

None

Popular Filters

1 to 25 of 1222 results

PHARMAC tender for generic medicines contributes NZ$38 million savings

PHARMAC tender for generic medicines contributes NZ$38 million savings

18-08-2014

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14…

Atypical antipsychoticsFinancialGenericsHealthcareNew Zealand

Amneal Pharma launches four new generics

Amneal Pharma launches four new generics

14-08-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals’ fast-growing portfolio of approved generic…

AcyclovirAmneal PharmaceuticalsCleocinGenericsMarkets & MarketingMepronRoxicodoneUSAZovirax

Sanofi unit launches authorized generic of Eloxatin

Sanofi unit launches authorized generic of Eloxatin

12-08-2014

The US subsidiary of French pharma major Sanofi says it has launched an authorized generic version of…

Advanced colorectal cancerEloxatinGenericsMarkets & MarketingOncologyOxaliplatinSanofiUSA

Despite difficult environment, Stada Arz posts solid results

Despite difficult environment, Stada Arz posts solid results

11-08-2014

German generic and branded drugmaker Stada Arzneimittel says that, in the first half of 2014, the group’s…

Business FinanceFinancialGenericsGermanyGermanySTADA Arzneimittel

Europe to boost cooperation with international partners on generics

Europe to boost cooperation with international partners on generics

08-08-2014

The European Union’s decentralized procedure is being used as a model to accelerate the assessment…

EuropeEuropean UnionGenericsGlobalRegulation

Generics production predicted to return to the USA due to quality concerns

Generics production predicted to return to the USA due to quality concerns

08-08-2014

Generics production represents a huge area of growth for the US market, which is partially driven by…

Business FinanceCPhI Pharma Insights USAGenericsProductionUSA

US Senators call for immediate release of guidance on biosimilar drugs

US Senators call for immediate release of guidance on biosimilar drugs

06-08-2014

US Senators Lamar Alexander (Republican, Tennessee) and Orrin Hatch (Rep, Utah) have led colleagues in…

BiosimilarsGenericsPoliticsRegulationUS Food and Drug AdministrationUSA

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

31-07-2014

Israel’s Teva Pharmaceutical Industries, the world’s biggest generics drugmaker, reported disappointing…

CopaxoneFinancialGenericsIsraelTeva Pharmaceutical Industries

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Indian generic drugmakers set to score from MPP deals on HIV drugs

Indian generic drugmakers set to score from MPP deals on HIV drugs

28-07-2014

Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation…

Anti-viralsGenericsIndiaLicensingPatentsProduction

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

Medicines Patent Pool broadens collaboration with Gilead Sciences

24-07-2014

The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Hospira’s Retacrit effective in chemotherapy-induced anemia

Hospira’s Retacrit effective in chemotherapy-induced anemia

24-07-2014

USA-based Hospira, a leading provider of generic injectable drugs and infusion technologies, announced…

BiosimilarsErythropoiesis-stimulating agentsGenericsHematologyHospiraInfusion technologiesResearchRetacritUSA

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

1 to 25 of 1222 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top